Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

BACKGROUND: We investigated low-dose aspirin (ASA) efficacy and safety in subjects with silent brain infarcts (SBIs) in preventing new cerebrovascular (CVD) events as well as cognitive impairment. METHODS: We included subjects aged ≥45 years, with at least one SBI and no previous CVD. Subjects were...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Stroke Res Treat
المؤلفون الرئيسيون: Maestrini, Ilaria, Altieri, Marta, Di Clemente, Laura, Vicenzini, Edoardo, Pantano, Patrizia, Raz, Eytan, Silvestrini, Mauro, Provinciali, Leandro, Paolino, Isabella, Marini, Carmine, Di Giuseppe, Matteo, Russo, Tommasina, Federico, Francesco, Coppola, Cristiana, Prontera, Maria Pia, Mezzapesa, Domenico Maria, Lucivero, Vincenzo, Parnetti, Lucilla, Sarchielli, Paola, Peducci, Maria, Inzitari, Domenico, Carlucci, Giovanna, Serrati, Carlo, Zat, Carla, Cavallini, Anna, Persico, Alessandra, Micieli, Giuseppe, Bastianello, Stefano, Di Piero, Vittorio
التنسيق: Artigo
اللغة:Inglês
منشور في: Hindawi 2018
الموضوعات:
Clinical Study
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192130/
https://ncbi.nlm.nih.gov/pubmed/30402216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7532403
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة